{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-022193","form_type":"8-K","ticker":"TRAW","cik":"0001130598","company_name":"Traws Pharma, Inc.","filed_at":"2025-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.004237+00:00","generated_at":"2026-05-25T00:49:32.456058+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Traws Pharma enters ATM equity facility for up to $50M with Citizens JMP Securities","bullets":["ATM agreement allows sale of common stock up to $50M aggregate, subject to baby shelf limit of $5,514,200.","Shares sold at market prices on Nasdaq via Citizens JMP as agent; commission is 3% of gross proceeds.","Prospectus supplement dated March 10, 2025 filed under Rule 424(b); Company not obligated to sell any shares.","ATM may be terminated by Company with 5 business days' notice or by Manager at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-022193","json":"https://secwatch.observer/filing/0001104659-25-022193.json","markdown":"https://secwatch.observer/filing/0001104659-25-022193.md","text":"https://secwatch.observer/filing/0001104659-25-022193.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925022193/0001104659-25-022193-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925022193/tm258583d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T00:49:32.456058+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}